发明授权
- 专利标题： Anti-IgSF4 antibody and utilization of the same
- 专利标题（中）： 抗IgSF4抗体与利用相同
-
申请号： US11885245申请日： 2006-02-22
-
公开(公告)号： US08048992B2公开(公告)日： 2011-11-01
- 发明人: Yoshikazu Kurosawa , Yasushi Akahori , Nobuhiro Takahashi , Atsushi Sugioka , Nobuhiro Hayashi , Akihiko Takasaki , Kazuhiro Suzuki , Miwa Morita , Gene Kurosawa , Sari Fujiyama , Susumu Tsustumi , Keiko Ogawa , Kazuki Matsuda , Chiho Muramatsu , Yoshitaka Iba , Mariko Sumitomo , Masachika Azuma , Yoshinori Ukai , Kazuhiro Morishita
- 申请人： Yoshikazu Kurosawa , Yasushi Akahori , Nobuhiro Takahashi , Atsushi Sugioka , Nobuhiro Hayashi , Akihiko Takasaki , Kazuhiro Suzuki , Miwa Morita , Gene Kurosawa , Sari Fujiyama , Susumu Tsustumi , Keiko Ogawa , Kazuki Matsuda , Chiho Muramatsu , Yoshitaka Iba , Mariko Sumitomo , Masachika Azuma , Yoshinori Ukai , Kazuhiro Morishita
- 申请人地址： JP Nagoya JP Nagoya
- 专利权人： Institute for Antibodies Co., Ltd.,Yoshikazu Kurosawa
- 当前专利权人： Institute for Antibodies Co., Ltd.,Yoshikazu Kurosawa
- 当前专利权人地址： JP Nagoya JP Nagoya
- 代理机构： Edwards Angell Palmer & Dodge LLP
- 优先权： JP2005-054624 20050228
- 国际申请： PCT/JP2006/303195 WO 20060222
- 国际公布： WO2006/090750 WO 20060831
- 主分类号： C07K16/00
- IPC分类号： C07K16/00
摘要：
It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
公开/授权文献
- US20090053243A1 Anti-IgSF4 Antibody and Utilization of the Same 公开/授权日：2009-02-26
信息查询
